Kolexia
Dadone-Montaudie Berengere Anatomie et cytologie
Dadone-Montaudie Berengere
Anatomie et cytologie
Hôpital Pasteur
Nice, France
65 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs cutanées Sarcomes Carcinomes Léiomyosarcome Liposarcome Néphrocarcinome Tumeurs du rein Tumeurs des tissus mous Nausée

Collaborateurs

Voir plus
Pedeutour Florence
Pedeutour Florence
Centre Antoine Lacassagne, Nice, France
Ambrosetti Damien
Ambrosetti Damien
Hôpital Pasteur, Nice, France
Burel-Vandenbos Fanny
Burel-Vandenbos Fanny
Hôpital Pasteur, Nice, France
Leccia Nathalie
Leccia Nathalie
Hôpital Pasteur, Nice, France

Industries

Voir plus
AstraZeneca
5 collaboration(s)
Dernière en 2022
Incyte
1 collaboration(s)
Dernière en 2022
Pfizer
1 collaboration(s)
Dernière en 2023
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with Venetoclax-Azacitidine (VEN-AZA) for Newly Diagnosed Acute Myeloid Leukemia. a Multicentric Real-Life Study of 117 Patients
65th ASH Annual Meeting Abstracts   02 novembre 2023
Vanished MDM2 amplification in multiple recurrences of an irradiated poorly differentiated sarcoma with amplified TRIO::TERT fusion gene.
Genes, chromosomes & cancer   27 mars 2023
Comment on "Clinicopathological and molecular analysis of cutaneous leiomyosarcoma: A retrospective multicenter study of 79 cases".
Journal of the American Academy of Dermatology   18 mars 2023
BRCA1/2 Pathogenic Variants Are Not Common in Merkel Cell Carcinoma: Comprehensive Molecular Study of 30 Cases and Meta-Analysis of the Literature.
The Journal of investigative dermatology   07 février 2023
Onychomatricoma: a clinicopathological, immunohistochemical, and molecular study of 10 cases highlighting recurrent RB1 deletion and the potential diagnostic value of LEF-1.
Histopathology   24 janvier 2023
Unmodified Dose of Azacitidine Plus Venetoclax Regimen without Drug Interactions during the First Cycle Leads to Similar Outcomes between Viale-a Clinical Trial and Real-Life in Acute Myeloid Leukemia
Annual Meeting Abstracts 2022   15 novembre 2022
Comparison of Risk Stratification Tools (ELN-2022, ELN-2017, Lindsley et al., Papaemmanuil et al. and ALFA classifier) in Predicting Outcomes of Patients with Acute Myeloid Leukemia
Annual Meeting Abstracts 2022   15 novembre 2022
Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study.
Journal of hematology & oncology   27 octobre 2022
AGAP3: A novel BRAF fusion partner in pediatric pancreatic-type acinar cell carcinoma.
Genes, chromosomes & cancer   31 août 2022
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort.
Nature medicine   26 mai 2022